Net Income Changement Date
AbbVie USD 822M 956M 2023-12
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
ALKERMES USD 47.76M 189.31M 2023-09
Alnylam Pharmaceuticals USD -137870000 285.62M 2023-12
Amgen USD 767M 963M 2023-12
Biogen USD 249.7M 317.8M 2023-12
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Cytokinetics USD -136896000 7.47M 2023-12
Dynavax Technologies USD 219K 14.07M 2023-12
Enanta Pharmaceuticals USD -28107000 10.96M 2023-09
Exelixis USD 1.04M 80.14M 2023-09
Gilead Sciences USD 1.43B 751M 2023-12
Halozyme Therapeutics USD 85.39M 3.55M 2023-12
Incyte USD 201.08M 29.81M 2023-12
Intra Cellular Therapies USD -28579000 4.32M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Nektar Therapeutics USD -45837000 5.28M 2023-09
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Pfizer USD -3368000000 986M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Repligen USD -25488000 43.66M 2023-12
Rigel Pharmaceuticals USD -5692000 908K 2023-09
Sarepta Therapeutics USD -40937000 17M 2023-09
Teva Pharmaceutical Industries USD 79M 941M 2023-09
Ultragenyx Pharmaceutical USD -123190000 36.46M 2023-12
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09
Xoma USD -5509000 109K 2023-09



Neurocrine Biosciences Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.